BioVU Archive — Page 6 of 8
-
July 8, 2019
Clinical study tests drug that may prevent cancer metastasis
A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center. -
April 24, 2019
Study merges big data and zebrafish biology to reveal mechanisms of human disease
In a series of studies that volleyed between large databases and research in zebrafish, Vanderbilt investigators have discovered a link between vascular biology and eye disease. -
February 7, 2019
PheWAS Core helps researchers make sense of electronic health record data
Some biomedical researchers may be unsure about routine electronic health record (EHR) data and how useful it ultimately may prove for drawing meaningful, actionable associations that warrant changes to clinical practice and lead to improved clinical outcomes. -
January 31, 2019
Study explores genetic risk for suicide attempt
Using data from the UK Biobank and Vanderbilt’s BioVU, a new study in the journal Molecular Psychiatry finds that approximately 4 percent of suicide attempt risk is captured by genotype data. -
December 31, 2018
Hundreds of new blood pressure gene variations discovered
-
October 25, 2018
Grant to help explore critical issues in Down syndrome
The Vanderbilt Kennedy Center (VKC) has received a one-year $604,000 grant from the National Institute of Child Health and Human Development (NICHD) to use Vanderbilt University Medical Center electronic medical record information and biological samples to develop a deeper understanding of critical issues in Down syndrome and to provide an infrastructure for future analyses. -
October 15, 2018
Malin elected to National Academy of Medicine
Bradley Malin, PhD, professor of Biomedical Informatics, Biostatistics and Computer Science, is among 85 newly elected members of the National Academy of Medicine (NAM), the organization announced this week.